ALLE
39
4
TRIP
52
3
TAP
43
2
SLG
77
3
UHS
54
-8
CHD
56
-2
RHI
40
2
ES
34
-2
GS
70
2
BRK.B
34
-2
GOOG
87
-2
BLK
66
2
PBI
43
5
URBN
50
-12
VIX
25
4
DTE
47
-2
SYY
50
-2
AXP
67
4
MCD
54
-5
PDCO
60
2
ALLE
39
4
TRIP
52
3
TAP
43
2
SLG
77
3
UHS
54
-8
CHD
56
-2
RHI
40
2
ES
34
-2
GS
70
2
BRK.B
34
-2
GOOG
87
-2
BLK
66
2
PBI
43
5
URBN
50
-12
VIX
25
4
DTE
47
-2
SYY
50
-2
AXP
67
4
MCD
54
-5
PDCO
60
2
Financhill
Back

DraftKings Vs. Keros Therapeutics Industry Stock Comparison

Sell
46

DKNG
DraftKings

Last Price:
38.17
Seasonality Move:
12.4%
Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
4.22%
Sell
46
DraftKings (DKNG) is a Sell

Is DraftKings a Buy, Sell or Hold?

  • The current DraftKings [DKNG] share price is $38.17. The Score for DKNG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DKNG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DKNG Stock Price Chart

What is DraftKings's stock price today?

  • The DraftKings share price today is $38.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DKNG is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

DKNG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 44.5 Sell
Chaikin Money Flow: 8719205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.12 - 40.78) Sell
Bollinger Bands (100): (39.25 - 45.13) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

DKNG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.9 Sell
20-day SMA: 38.58 Sell
50-day SMA: 40.63 Sell
200-day SMA: 37.95 Buy
8-day EMA: 38.84 Sell
20-day EMA: 39.31 Sell
50-day EMA: 40.33 Sell
200-day EMA: 37.65 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

DraftKings Earnings Growth & DKNG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.55 per share, an increase this year of $1.60 per share, and an increase next year of $0.92 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

DraftKings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):